8 SEPTEMBER 2005

NEW ZEALAND GAZETTE, No. 154

Cyclizine; for oral use
Cyproheptadine; for oral use
Dexchlorpheniramine; for oral use except when specified
elsewhere in the Schedule
Dimenhydrinate; for oral use except when specified
elsewhere in the Schedule
Dimethindene; for oral use
Diphenhydramine; for oral use except when specified
elsewhere in the Schedule
Diphenylpyraline; for oral use except when specified
elsewhere in the Schedule
Doxylamine; for oral use except when specified elsewhere
in the Schedule
Methdilazine; for oral use
Orlistat; in medicines containing 120 milligrams or less per
dose form for the purpose of weight control
Pheniramine; for oral use except when specified elsewhere
in the Schedule
Phenyltoloxamine; for oral use
Promethazine; for oral use except when specified elsewhere
in the Schedule
Stramonium; for oral use in liquid form; in solid dose form
in medicines containing more than 0.3 milligrams per
dose or more than 1.2 milligrams per recommended
daily dose
Thenyldiamine; for oral use in solid dose form or in liquid
form containing 10 milligrams or less of thenyldiamine
per 5 millilitres except when specified elsewhere in the
Schedule
Trimeprazine; for oral use in solid dose form or in liquid
form containing 10 milligrams or less per 5 millilitres;
except when specified elsewhere in the Schedule
Triprolidine; for oral use except when specified elsewhere in
the Schedule

Schedule 3
Pharmacy-only Medicines

Aciclovir; for external use for the treatment of herpes
labialis except in medicines containing 5% or less and
in tubes containing 10 grams or less
Antazoline; for ophthalmic use
Benzocaine; in mouthwashes containing 10% or less; for
external use in medicines other than mouthwashes
containing 10% or less and more than 2% except in
throat lozenges containing 30 milligrams or less per dose
form
Brompheniramine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing brompheniramine in the bedtime dose and in
preparations for adults or children two years of age or
more
Chlorpheniramine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing chlorpheniramine in the bedtime dose and in
preparations for adults or children two years of age or
more
Dexchlorpheniramine; for oral use when combined with one
or more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing dexchlorpheniramine in the bedtime dose and
in preparations for adults or children two years of age or
more
Dibrompropamidine; for ophthalmic use
Dimenhydrinate; for oral use in a sealed container of not
more than 10 tablets or capsules for the prevention or
treatment of motion sickness except when sold at a
transport terminal or aboard a ship or plane
Diphenhydramine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing diphenhydramine in the bedtime dose and
in preparations for adults or children two years of
age or more; in a sealed container of not more than
10 tablets or capsules of diphenhydramine theoclate for
the prevention or treatment of motion sickness except
when sold at a transport terminal or aboard a ship or
plane
Diphenylpyraline; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing diphenylpyraline in the bedtime dose and in
preparations for adults or children two years of age or
more
Doxylamine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing doxylamine in the bedtime dose and in
preparations for adults or children two years of age or
more
Meclozine; in a sealed container of not more than 12 tablets
or capsules for the prevention of travel sickness except
when sold at a transport terminal or aboard a ship or
plane
Mepyramine; for dermal use
Naphazoline
Pheniramine; for ophthalmic use; for oral use when
combined with one or more other therapeutically active
substances for the treatment of coughs, colds or
influenza when at least one of the other therapeutically
active substances is a sympathomimetic decongestant
or in a day/night pack containing pheniramine in the
bedtime dose and in preparations for adults or children
two years of age or more
Promethazine; for oral use when combined with one or
more other therapeutically active substances for the
treatment of coughs, colds or influenza when at least
one of the other therapeutically active substances is a
sympathomimetic decongestant or in a day/night pack
containing promethazine in the bedtime dose and in
preparations for adults or children two years of
age or more; in a sealed container of not more than
10 tablets or capsules for the prevention or treatment of
motion sickness except when sold at a transport terminal
or aboard a ship or plane
Propamidine; for ophthalmic use
Stramonium; in solid dose form in medicines containing 0.3
milligrams or less per dose and 1.2 milligrams or less per
recommended daily dose
Thenyldiamine; for nasal use; for oral use when combined
with one or more other therapeutically active substances
for the treatment of coughs, colds or influenza when at
least one of the other therapeutically active substances is